Study shows “significant improvement” in memory loss

The FDA claims a cutting-edge Alzheimer’s treatment that has delivered hope to hundreds....... [Click here](1770d7/ct0_0/1/ms?sid=TV2%3AxismYIy8N) to view this message in your browser | [Click here](1770d7/l-002e/zout?sid=TV2%3AxismYIy8N) to stop receiving our messages [] [] Al Sears, MD 11905 Southern Blvd. Royal Palm Beach, FL 33411 [] June 29, 2023 [] Reader, The FDA claims a cutting-edge Alzheimer’s treatment that has delivered hope to hundreds of desperate patients and their families “has not been clinically proven.”1 Of course, this comes from a government agency that is willing to turn a blind eye to any health solution that doesn’t benefit them – directly or indirectly – in a big way. It’s just further evidence that the FDA doesn’t have your best interests at heart. Profit and the cozy connection they share with their buddies at Big Pharma are what matters most to them. The treatment I’m talking about is hyperbaric oxygen. Let me give you one clinical study example of what this “unproven” therapy can do... The patient was a 58-year-old woman who had been diagnosed with Alzheimer’s disease five years earlier. [hbot brain] After HBOT, this Alzheimer’s patient’s brain is once again wide awake and active. By the time my colleague, Dr. Paul Harch, saw her she couldn’t remember her own children. She wasn’t able to have a conversation. And she needed constant, around-the-clock care. If you’re a regular reader, you’ll remember that Dr. Harch was a keynote speaker at my Confidential Cures Summit. He is a clinical professor and director of hyperbaric medicine at the LSU School of Medicine. Today he is recognized as one of the preeminent authorities on HBOT research in the world. Scans taken of this patient’s brain before HBOT showed that it was almost 100% inactive. You can see it on the right. It shows up almost entirely green. A healthy brain has areas of red and yellow. Now take a look at the scan below it. This is the same patient’s brain — just a few weeks later. You can see from all the lit-up areas that this brain is awake and active. This is a brain that can remember her children’s names and faces... It’s a brain that can carry on a conversation with her loved ones. The scans you’re seeing provide visible proof that the treatment works! As Dr. Harch told the audience at my summit: “Even a third grader could look at these images and say that the patient looks better!” Today this patient has regained much of what the disease had stolen from her. Her memory, mood, and concentration improved, as did her ability to do crossword puzzles, use the computer, and return to her normal activities of daily living.2 Of course, this study isn’t the only clinical trial that proves HBOT can repair the brain. In a 2020 study published in the journal Alzheimer’s Dementia, researchers recruited 53 patients with either Alzheimer’s or mild cognitive impairment. Another 30 Alzheimer’s patients acted as a control group. The 53 patients in the first group were treated with 40 minutes of HBOT once a day for 20 days. All were assessed by a series of neuropsychiatric tests before and after therapy.3 The researchers report that HBOT therapy significantly improved cognitive function after one month compared to the control group. In the patients with mild cognitive impairment, the results were more impressive and lasted even longer. And an Israeli study showed equally impressive results. [dr. paul] Dr. Paul Harch, a keynote speaker at my regenerative medicine summit, is the world’s leading authority on HBOT brain research. Researchers at the Shamir Medical Center gathered six patients over the age of 65. All had early-stage Alzheimer’s with significant memory loss. The participants were treated with 60 daily HBOT sessions over a three-month period. High-resolution imaging before and after treatment revealed that HBOT improved cerebral blood flow in several brain areas, with increases of 16 to 23%. Poor blood flow to the brain has long been seen as an early warning sign of Alzheimer’s — but there is now strong scientific evidence that it’s a root cause. Overall cognitive scores also improved, jumping from 102 to 109.5. And memory scores increased by a dramatic 27%.4 At the Sears Institute for Anti-Aging Medicine, we’ve been bringing hope to the hopeless using HBOT for almost a decade. And I’m not talking about just patients with cognitive decline. We also use this breakthrough therapy to treat: - Stroke - Traumatic brain injury - Diabetes - Depression - Post traumatic stress disorder - Wound healing - Multiple sclerosis - Autoimmune disease - Autism - Stem cell and telomerase activation - Bone regeneration - Long Covid recovery Because of the FDA regulations I mentioned earlier, I’m not supposed to tell you that HBOT can treat all these conditions better than Big Pharma’s approved drugs. But I won’t let the FDA keep me from taking my commitment to your health seriously. To Your Good Health, Al Sears, MD, CNS --------------------------------------------------------------- References: 1. “Get the facts.” www.fda.gov/consumers/consumer-updates/hyperbaric-oxygen-therapyget- facts. Accessed on June 20, 2023. 2. Harch P and Fogarty E. “Hyperbaric oxygen therapy for Alzheimer’s dementia with positron emission tomography imaging: A case report.” Med Gas Res. 2018:8(4)181-184. 3. Chen J, et al. “Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment.” Alzheimers Dement (N Y). [v.6(1); 2020](1770d7/ct1_0/1/lu?sid=TV2%3AxismYIy8N). 4. Shapira R, et al. “Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer's disease mouse model and in elderly patients.” Aging (Albany NY). 2021 Sep 9;13(17):20935-20961. alsearsmd@send.alsearsmd.com [Preferences | Unsubscribe](1770d7/l-002e/zout?sid=TV2%3AxismYIy8N) 11905 Southern Blvd., Royal Palm Beach, Florida 33411, United States